Positive blood cultures in a patient recovering from febrile neutropenia

References

1. Carrillo A. J., Guarro J.. 2001; In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother45:2151–2153 [CrossRef][PubMed]
   [Google Scholar]
2. Compain F., Botterel F., Sitterlé E., Paugam A., Bougnoux M. E., Dannaoui E.. 2015; In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp. J Med Microbiol64:309–311 [CrossRef][PubMed]
   [Google Scholar]
3. Cortez K. J., Roilides E., Quiroz-Telles F., Meletiadis J., Antachopoulos C., Knudsen T., Buchanan W., Milanovich J., Sutton D. A., other authors. 2008; Infections caused by Scedosporium spp. Clin Microbiol Rev21:157–197 [CrossRef][PubMed]
   [Google Scholar]
4. Cuenca-Estrella M., Ruiz-Díez B., Martínez-Suárez J. V., Monzón A., Rodríguez-Tudela J. L.. 1999; Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum . J Antimicrob Chemother43:149–151[PubMed][CrossRef]
   [Google Scholar]
5. Howden B. P., Slavin M. A., Schwarer A. P., Mijch A. M.. 2003; Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis22:111–113 [CrossRef][PubMed]
   [Google Scholar]
6. Husain S., Munoz P., Forrest G., Alexander B. D., Somani J., Brennan K., Wagener M. M., Singh N.. 2005; Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infec Dis40:89–99 [CrossRef]
   [Google Scholar]
7. Kesson A. M., Bellemore M. C., O'Mara T. J., Ellis D. H., Sorrell T. C.. 2009; Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis48:1257–1261 [CrossRef][PubMed]
   [Google Scholar]
8. Meletiadis J., Meis J. F., Mouton J. W., Rodriquez-Tudela J. L., Donnelly J. P., Verweij P. E.. EUROFUNG Network 2002; In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother46:62–68 [CrossRef][PubMed]
   [Google Scholar]
9. Meletiadis J., Mouton J. W., Meis J. F., Verweij P. E.. 2003; In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother47:106–117 [CrossRef][PubMed]
   [Google Scholar]
10. Ortoneda M., Pastor F. J., Mayayo E., Guarro J.. 2002; Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model. J Med Microbiol51:924–928 [CrossRef][PubMed]
    [Google Scholar]
11. Rodriguez-Tudela J. L., Berenguer J., Guarro J., Kantarcioglu A. S., Horre R., de Hoog G. S., Cuenca-Estrella M.. 2009; Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol47:359–370 [CrossRef][PubMed]
    [Google Scholar]
12. Tortorano A. M., Richardson M., Roilides E., van Diepeningen A., Caira M., Munoz P., Johnson E., Meletiadis J., Pana Z. D., other authors. 2014; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect Suppl3:27–46[CrossRef]
    [Google Scholar]
13. Trubiano J. A., Paratz E., Wolf M., Teh B. W., Todaro M., Thursky K. A., Slavin M. A.. 2014; Disseminated Scedosporium prolificans infection in an 'extensive metaboliser': navigating the minefield of drug interactions and pharmacogenomics. Mycoses57:572–576 [CrossRef][PubMed]
    [Google Scholar]
14. Whyte M., Irving H., O'Regan P., Nissen M., Siebert D., Labrom R.. 2005; Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia. Pediatr Infect Dis J24:375–377[PubMed][CrossRef]
    [Google Scholar]